MSI Developing New Medicines - Leveraging Known Pharmacology
OVERVIEW
METHYLATIONSCIENCES.COM RANKINGS
Date Range
Date Range
Date Range
METHYLATIONSCIENCES.COM HISTORY
PERIOD OF EXISTANCE
LINKS TO BUSINESS
Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout. Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury. Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science. May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel. Inventages, formed with the support of Nestlé.
Thursday, February 26, 2015. Ready to Rocket Presentation 2015. Here is the briefing provided to investors and advisors of technology companies in Vancouver on February 26th 2015 at Harbour Centre.
WHAT DOES METHYLATIONSCIENCES.COM LOOK LIKE?
CONTACTS
Methylation Sciences Inc
Barry GULD
#108, 4475 Wayburne Drive
Burnaby, BC, V5G 4X4
Canada
METHYLATIONSCIENCES.COM HOST
NAME SERVERS
BOOKMARK ICON
TITLE
MSI Developing New Medicines - Leveraging Known PharmacologyDESCRIPTION
Developing New Medicines - Leveraging Known Pharmacology. Developing New Medicines - Leveraging Known Pharmacology. MSI Methylation Sciences Inc. MSI Methylation Sciences Inc. is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. Strada , our lead product, is targeting Major Depressive Disorder. Additionally, MSI-195 was well tolerated. No serious adv.CONTENT
This website has the following in the web page, "Developing New Medicines - Leveraging Known Pharmacology." Our analyzers analyzed that the web site also stated " Developing New Medicines - Leveraging Known Pharmacology." The Website also stated " is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. Strada , our lead product, is targeting Major Depressive Disorder. Additionally, MSI-195 was well tolerated."OTHER BUSINESSES
Introduction à la POO avec PHP. Les variables de configuration avec PHP. Chargée de communication à Toulouse. Aurelien Malagoli, Webdesigner, Graphiste. Damien Gasc, Conseiller Clientèle, Toulouse.
Do You Need A B12 Supplement? Choosing a B12 Supplement. The Benefits Of Sublingual Methylcobalamin. Vitamin B12 and Methylcobalamin What Are They? What Vitamin B12 Actually Does. Will Cyanocobalamin Kill Me? B12 Overdose And Side Effects. Why Washing Rice Is Dangerous.